Diabetes mellitus is a common chronic condition and an old friend to family physicians practising in the community. The long-standing practice had aimed to lower glucose levels in type 2 diabetes to prevent long-term complications. The recent evidence from some publications since June 2008 had suggested the possible harm to our patients when we adopt intensive treatment strategies with tight treatment control targets (below HbA1c of 6%) and many meta-analyses have been published. This review highlights the evidence from recent studies that shook the previous dogma and the new clinical equipoise.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183–97.
3.
Action to Control Cardiovascular Risk in Diabetes Study Group, GersteinHCMillerMEByingtonRPGoffDCJrBiggerJT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545–59. Epub 2008 Jun 6.
4.
JadadARMooreRACarrollDJenkinsonCReynoldsDJGavaghanDJ. Assessing the quality of reports on randomized clinical trials: Is blinding necessary?Control Clin Trials. 1996;17(1):1–12.
5.
ADVANCE Collaborative Group, PatelAMacMahonSChalmersJNealBBillotL. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560–72. Epub 2008 Jun 6.
6.
DuckworthWAbrairaCMortizTRedaDEmanueleNReavenPD. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 8;360(2):129–39. Epub 2008 Dec 17.
7.
HolmanRRPaulSJBethelMAMatthewDRNeilHA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 9;359(15):1577–89. Epub 2008 Sep 10.
8.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complication Trial Research Group. N Engl J Med. 1993;329(14):977–86.
9.
NathanDMClearyPABacklundJYGenuthSMLachinJMOrchardTJ. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53.
10.
GaedePLund-AndersenHParvingHHPedersenO. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008 Feb 7;358(6):580–91.
11.
CurrieCJPetersJRTynanAEvansMHeineRJBraccoOL. Survival as a function of HbA1c in people with type 2 diabetes: A retrospective cohort study. Lancet. 2010;375(9713):481–89. Epub 2010 January 27.
12.
RayKKSeshasaiSRWijesuriyaSSivakumaranRNethercottSPreissD. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–72.
13.
Control Group, TurnbullFMAbrairaCAndersonRJByingtonRPChalmersJP. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52(11):2288–98.
14.
KellyTNBazzanoLAFonsecaVAThethiTKReynoldsKHeJ. Systematic review: Glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med. 2009;151(6):394–403.
